A Study to Learn More About the Safety and the Blood Level of BAY1747846 Given as Injection Into the Vein at Increasing Single Doses in Chinese Healthy Male Participants

NCT06135181 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Contrast Enhancement in Magnetic Resonance Imaging
Healthy Volunteers

Interventions

DRUG: Gadoquatrane (BAY1747846) 0.03 mmol Gd/kg
DRUG: Gadoquatrane (BAY1747846) 0.1 mmol Gd/kg
DRUG: Matching placebo

Sponsor

Bayer